Chimeric Therapeutics

(ASX) CHM

Current Price$0.20

Market CapN/A

Since IPO (2021)-99%

5 Year-99%

1 Year-60%

1 Month+0%

Chimeric Therapeutics Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$7.36M

Net Income (TTM)

$32.83M

EPS (TTM)

$-0.72

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.36 (Low)

Dividend

$0.00

Beta (Volatility)

0.36 (Low)

Price

$0.20

Volume

Open

$0.21

Price

$0.20

Volume

Open

$0.21

Previous Close

$0.20

Daily Range

$0.20 - $0.21

52-Week Range

$0.10 - $0.90

Dividend

$0.00

Beta (Volatility)

0.36 (Low)

Price

$0.20

Volume

Open

$0.21

Previous Close

$0.20

Daily Range

$0.20 - $0.21

52-Week Range

$0.10 - $0.90

CHM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Chimeric Therapeutics

Industry

Biotechnology

Sector

Health Care

CEO

Rebecca McQualter, PhD

Website

www.chimerictherapeutics.com

Headquarters

Carlton, VIC 3053, AU

CHM Financials

Key Financial Metrics (TTM)

Gross Margin

74%

Operating Margin

-5%

Net Income Margin

-4%

Return on Equity

-1291%

Return on Capital

11%

Return on Assets

-3%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$0.00

Shares Outstanding

Volume

Avg. Volume

62.69K

Financials (TTM)

Gross Profit

$3.12M

Operating Income

$15.11M

EBITDA

$9.08M

Operating Cash Flow

$7.28M

Capital Expenditure

$0.00

Free Cash Flow

$7.28M

Cash & ST Invst.

$5.76M

Total Debt

$0.00

Chimeric Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$486.78K

-109.7%

Gross Margin

0.00%

N/A

Market Cap

$0.00

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$11.22M

-558.9%

EBITDA

$3.40M

-28.3%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Net Cash

$2.50M

-29.0%

Accounts Receivable

$2.53M

-75.9%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-2.53%

N/A

Return on Invested Capital

11.24%

N/A

Free Cash Flow

$3.84M

+17.5%

Operating Cash Flow

$3.84M

+17.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

IXC.AXInvex Therapeutics Ltd

IXC.AXInvex Therapeutics Ltd$0.13+0.00%

CAN.AXCann Group Limited

CAN.AXCann Group Limited$0.01-0.00%

BGT.AXBio-Gene Technology Limited

BGT.AXBio-Gene Technology Limited$0.04+0.00%

BIT.AXBiotron Limited

BIT.AXBiotron Limited$0.00+20.00%

PER.AXPercheron Therapeutics Limited

PER.AXPercheron Therapeutics Limited$0.01+11.11%

1AD.AXAdAlta Limited

1AD.AXAdAlta Limited$0.01+0.00%

HIQ.AXHITIQ Limited

HIQ.AXHITIQ Limited$0.01+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SOFISoFi Technologies

SOFISoFi Technologies$16.10+0.04%

AAPLApple

AAPLApple$271.35+0.00%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.63+0.10%

MARAMara Holdings

MARAMara Holdings$11.99+0.12%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$63.54+0.03%

FFord Motor Company

FFord Motor Company$12.08-0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.47+0.05%

Questions About CHM

What is the current price of Chimeric Therapeutics?

Chimeric Therapeutics is trading at A$0.20 per share.

What is the 52-week range for Chimeric Therapeutics?

Over the past 52 weeks, Chimeric Therapeutics has traded between A$0.10 and A$0.90.

How much debt does Chimeric Therapeutics have?

As of the most recent reporting period, Chimeric Therapeutics reported total debt of N/A.

How much cash does Chimeric Therapeutics have on hand?

Chimeric Therapeutics reported $5.76M in cash and cash equivalents in its most recent financial results.

What is Chimeric Therapeutics’s dividend yield?

Chimeric Therapeutics does not currently have a dividend yield.

Chimeric Therapeutics

Chimeric Therapeutics Financials at a Glance

CHM News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Chimeric Therapeutics

CHM Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Chimeric Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CHM

What is the current price of Chimeric Therapeutics?

What is the 52-week range for Chimeric Therapeutics?

How much debt does Chimeric Therapeutics have?

How much cash does Chimeric Therapeutics have on hand?

What is Chimeric Therapeutics’s dividend yield?

Premium Investing Services